The risk of invasive pneumococcal disease differs between risk groups in Norway following widespread use of the 13-valent pneumococcal vaccine in children
Peer reviewed, Journal article
Published version
View/ Open
Date
2021Metadata
Show full item recordCollections
- Artikler [5061]
- Publikasjoner fra CRIStin FHI [7531]